President and CEO Bilotto Christopher J. was granted 67,073 units of Common Shares of Beneficial Interest, increasing direct ownership by 22% to 366,515 units (SEC Form 4)
4 - Service Properties Trust (0000945394) (Issuer)
- Director Sanders Richard A was granted 94 shares, increasing direct ownership by 23% to 508 units (SEC Form 4)
4 - MERCADOLIBRE INC (0001099590) (Issuer)
- SEC Form 3 filed by new insider Zwick Jordan Michael
3 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Fraiche Donna D. was granted 67,073 units of Common Shares of Beneficial Interest, increasing direct ownership by 37% to 249,086 units (SEC Form 4)
4 - Service Properties Trust (0000945394) (Issuer)
- Director Burns Laurie B. was granted 67,073 units of Common Shares of Beneficial Interest (SEC Form 4)
4 - Service Properties Trust (0000945394) (Issuer)
- Chief Commercial Officer Karas Eric exercised 25,000 shares at a strike of $1.50 and sold $250,000 worth of shares (25,000 units at $10.00) as part of a pre-agreed trading plan (SEC Form 4)
4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by SVP, Chief Accounting Officer Cheung Kenneth
4 - Super Micro Computer, Inc. (0001375365) (Issuer)
- Director Cramer Robert E. was granted 67,073 units of Common Shares of Beneficial Interest, increasing direct ownership by 76% to 154,753 units (SEC Form 4)
4 - Service Properties Trust (0000945394) (Issuer)
- Director Lawson Martin R was granted 94 shares, increasing direct ownership by 2% to 4,230 units (SEC Form 4)
4 - MERCADOLIBRE INC (0001099590) (Issuer)
- Chief Legal Officer Fitzpatrick Alexander A sold $33,550 worth of shares (3,355 units at $10.00) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 90,910 units (SEC Form 4)
4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Penkar Rajan was granted 67,073 units of Common Shares of Beneficial Interest, increasing direct ownership by 671% to 77,073 units (SEC Form 4)
4 - Service Properties Trust (0000945394) (Issuer)
- Director Simson Jake was granted 5,500 shares (SEC Form 4)
4 - Janux Therapeutics, Inc. (0001817713) (Issuer)
- Director Hernday Natasha was granted 5,500 shares, increasing direct ownership by 55% to 15,481 units (SEC Form 4)
4 - Janux Therapeutics, Inc. (0001817713) (Issuer)
- Director Kung Winston was granted 5,500 shares, increasing direct ownership by 88% to 11,750 units (SEC Form 4)
4 - Janux Therapeutics, Inc. (0001817713) (Issuer)
- Director Capps Vickie L was granted 5,500 shares, increasing direct ownership by 7% to 79,598 units (SEC Form 4)
4 - Janux Therapeutics, Inc. (0001817713) (Issuer)
- Director Barrett Ronald W was granted 5,500 shares, increasing direct ownership by 88% to 11,750 units (SEC Form 4)
4 - Janux Therapeutics, Inc. (0001817713) (Issuer)
- Director Dobmeier Eric was granted 5,500 shares, increasing direct ownership by 55% to 15,481 units (SEC Form 4)
4 - Janux Therapeutics, Inc. (0001817713) (Issuer)